Global Veterinary Diagnostics Market - Global Forecast to 2027

Share

Global Veterinary Diagnostics Market - Global Forecast to 2027


 Category : Medical Devices

 Published: Nov-2021
 Author: SPER Analyst


Global Veterinary Diagnostics Market is projected to be worth $ x Billion by 2027

The global veterinary diagnostics market is expected to grow at a CAGR of ~x% from 2020 to reach ~x billion by 2027. The growth of this market is primarily attributed to growing companion animal population, prevalence of zoonotic diseases, growing demand for animal health insurance, increasing expenditure on animal health, rising demand for animal derived foods and increasing number of veterinary practitioners. However, rising pet care expenses, lack of skilled veterinarians and limitation of diagnostic infrastructure are expected to hinder the growth of the market. Rising use of PCR testing for COVID-19 in animals by pet owners provide great opportunities for this market.

Browse report overview on "Global Veterinary Diagnostics Market " at: https://www.sperresearch.com/report-store/Veterinary-Diagnostics.aspx

The global veterinary diagnostics market study provides market data for-by product (consumables, instruments), by animal type (companion, livestock), by technology (immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, urinalysis, other veterinary diagnostic technology. The study also evaluates industry competitors and analyses the market at a regional and country level.

By product, consumables segment accounted for largest share of veterinary diagnostics market in 2020. The large share is mainly attributed to grown demand of these products in veterinary hospitals, clinics & labs, adoption of point of care diagnostics by pet owners and rising awareness about zoonotic diseases

By animal type, companion animals segment accounted for the largest market share in 2020. The dominant share of companion animal segment was captured by dogs. The large market share is mainly attributed to increasing obesity, cancer, diabetes and other diseases and growing concern among pet owners. In livestock animal segment, pigs accounted for largest market share due to rising consumption of pork and diagnostic tests for them. 

Based on technology, molecular diagnostics segment accounted for largest share of veterinary diagnostics market. The large share of this segment is mainly driven by growing usage of molecular diagnosis for the detection of veterinary diseases and reliable, specific & fast diagnosis. COVID-19 has further propelled the application for the rapid detection of virus in companion animals. 

Don’t miss out on business opportunities in the "Global Veterinary Diagnostics Market". Request customized report as per your need and gain crucial industry insights that will help your business grow at: https://www.sperresearch.com/report-store/Veterinary-Diagnostics.aspx?custom=1

This research report analyses major geographies and provides a comprehensive analysis of North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, India, Japan, and RoAPAC), Rest of the world (Latin America, and Middle East & Africa). North America commanded largest market share of veterinary diagnostics market, by region. The largest share is attributed to increasing population of companion & livestock animals, rising consumption of meat & dairy products, technological advancement, rising pet insurance and growing healthcare expenditure on animals. APAC is expected to exhibit highest CAGR in the forecast period. The growth of this regional market is mainly driven by increasing disposable income, adoption of pet animals and high demand for animal protein.

The major players operating in the veterinary diagnostics market are 
  • Thermo Fisher Scientific Inc. (US)
  • Zoetis Inc. (US)
  • IDEXX Laboratories Inc. (US)
  • NEOGEN Corporation (US)
  • Bio-Rad Laboratories Inc. (US)
  • bioMérieux SA (France)
  • Virbac (France)
  • Heska Corporation (US)
  • Bio-Rad Laboratories Inc. (US)
  • bioMérieux SA (France)
  • Virbac (France)
  • Heska Corporation (US)
  • Agrolabo S.p.A. (Italy)
  • INDICAL BIOSCIENCE GmbH (Germany)
  • Randox Laboratories Ltd. (Ireland)
  • IDvet (France)
  • Biopanda Reagents (UK)
  • Bionote Inc. (South Korea)
  • BioChek (Netherlands)
  • Fassisi GmbH (Germany)
  • Biogal Galed Labs (Israel)
  • Alvedia (France)
  • SKYER Inc. (South Korea)
  • Shenzhen Bioeasy Biotechnology Co. Ltd. (China)

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-McKinsey
SPER-Bain
SPER-Max-Healthcare
SPER-DHL
SPER-SIEMENS
SPER-IQVIA
SPER-Pfizer
SPER-LOREAL
SPER-Kankar IMRB
SPER-ITA
SPER-PWC
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-IPSOS
SPER-Heineken

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]

 +91-742-898-5650